These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3290702)

  • 1. A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand.
    Croxson M; Brown P; Synek B; Harrington MG; Frith R; Clover G; Wilson J; Gajdusek DC
    Neurology; 1988 Jul; 38(7):1128-30. PubMed ID: 3290702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creutzfeldt-Jakob disease following pituitary-derived human growth hormone therapy: a new American case.
    Marzewski DJ; Towfighi J; Harrington MG; Merril CR; Brown P
    Neurology; 1988 Jul; 38(7):1131-3. PubMed ID: 3290703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The decline and fall of Creutzfeldt-Jakob disease associated with human growth hormone therapy.
    Brown P
    Neurology; 1988 Jul; 38(7):1135-7. PubMed ID: 3290705
    [No Abstract]   [Full Text] [Related]  

  • 4. Preclinical Creutzfeldt-Jakob disease discovered at autopsy in a human growth hormone recipient.
    New MI; Brown P; Temeck JW; Owens C; Hedley-Whyte ET; Richardson EP
    Neurology; 1988 Jul; 38(7):1133-4. PubMed ID: 3290704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal proteins in the cerebrospinal fluid of a patient with Creutzfeldt-Jakob disease following administration of human pituitary growth hormone.
    Macário ME; Moura-Neto V; Vaisman M; Araujo HM; Buescu A; Cordeiro JG; Chagas C
    Braz J Med Biol Res; 1992; 25(11):1127-30. PubMed ID: 1342593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathologic verification of Creutzfeldt-Jakob disease in the exhumed American recipient of human pituitary growth hormone: epidemiologic and pathogenetic implications.
    Tintner R; Brown P; Hedley-Whyte ET; Rappaport EB; Piccardo CP; Gajdusek DC
    Neurology; 1986 Jul; 36(7):932-6. PubMed ID: 3520381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A patient with Creutzfeldt-Jakob disease following treatment with human growth hormone].
    Roos RA; Wintzen AR; Will RG; Ironside JW; van Duinen SG
    Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1190-3. PubMed ID: 8692356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary growth hormone and Creutzfeldt-Jakob disease.
    Norrby E
    Acta Paediatr Scand Suppl; 1986; 325():116-24. PubMed ID: 3296633
    [No Abstract]   [Full Text] [Related]  

  • 9. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone.
    Koch TK; Berg BO; De Armond SJ; Gravina RF
    N Engl J Med; 1985 Sep; 313(12):731-3. PubMed ID: 3897861
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone.
    Gibbs CJ; Joy A; Heffner R; Franko M; Miyazaki M; Asher DM; Parisi JE; Brown PW; Gajdusek DC
    N Engl J Med; 1985 Sep; 313(12):734-8. PubMed ID: 2863752
    [No Abstract]   [Full Text] [Related]  

  • 11. Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom.
    Buchanan CR; Preece MA; Milner RD
    BMJ; 1991 Apr; 302(6780):824-8. PubMed ID: 2025705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Creutzfeldt-Jakob disease after treatment with human extracted growth hormone. A clinicopathological study].
    Delisle MB; Fabre N; Rochiccioli P; Doerr-Schott J; Rumeau JL; Bes A
    Rev Neurol (Paris); 1993; 149(10):524-7. PubMed ID: 8023064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iatrogenic Creutzfeldt-Jakob disease in three growth hormone recipients: a neuropathological study.
    Billette de Villemeur T; Gelot A; Deslys JP; Dormont D; Duyckaerts C; Jardin L; Denni J; Robain O
    Neuropathol Appl Neurobiol; 1994 Apr; 20(2):111-7. PubMed ID: 8072642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creutzfeldt-Jakob disease after pituitary-derived human growth hormone therapy: two cases with valine 129 homozygous genotype.
    Masson C; Delalande I; Deslys JP; Hénin D; Fallet-Bianco C; Dormont D; Leys D
    Neurology; 1994 Jan; 44(1):179-80. PubMed ID: 7904734
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathology of Creutzfeldt-Jakob disease associated with pituitary-derived human growth hormone administration.
    Weller RO; Steart PV; Powell-Jackson JD
    Neuropathol Appl Neurobiol; 1986; 12(2):117-29. PubMed ID: 3520369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Creutzfeldt-Jakob disease in 4 children treated with growth hormone].
    Billette de Villemeur T; Gourmelen M; Beauvais P; Rodriguez D; Vaudour G; Deslys JP; Dormont D; Richard P; Richardet JM
    Rev Neurol (Paris); 1992; 148(5):328-34. PubMed ID: 1448646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary growth hormone and Creutzfeldt-Jakob disease.
    Macario ME; Vaisman M; Buescu A; Moura Neto V; Araujo HM; Chagas C
    BMJ; 1991 May; 302(6785):1149. PubMed ID: 2043794
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical neurology and epidemiology of Creutzfeldt-Jakob disease, with special reference to iatrogenic cases.
    Brown P
    Ciba Found Symp; 1988; 135():3-23. PubMed ID: 3044708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creutzfeldt-Jakob disease in recipients of human growth hormone in the United Kingdom: a clinical and radiographic study.
    Markus HS; Duchen LW; Parkin EM; Kurtz AB; Jacobs HS; Costa DC; Harrison MJ
    Q J Med; 1992 Jan; 82(297):43-51. PubMed ID: 1438667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of Creutzfeldt-Jakob disease.
    Rodda RA
    Clin Exp Neurol; 1977; 14():108-16. PubMed ID: 358185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.